United States· US:68180-129_574221bf-1643-4dd4-8ac6-29f387ce5eaf
Fenofibric acid
A choline fenofibrate product containing choline fenofibrate, registered in United States by Lupin Pharmaceuticals, Inc.. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Choline fenofibrate is registered in 2 of 19 countries.
Countries holding a registration under ATC C10AB11 (choline fenofibrate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Choline fenofibrate · ATC C10AB11
2 / 19 countries
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CHOLINE FENOFIBRATE
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- C10AB11
- ATC class
- Choline fenofibrate
- Defined daily dose
- 0.135 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C10AB11
Choline fenofibrate, as other registers publish it.
- United StatesFenofibric acidMacleods Pharmaceuticals Limited
- United StatesFenofibric acidLupin Pharmaceuticals, Inc.
- United StatesFenofibric acidMacleods Pharmaceuticals Limited
- SwitzerlandTrilipix 135 mg, Hartkapseln, retardiertViatris Pharma GmbH
- SwitzerlandTrilipix 45 mg, Hartkapseln, retardiertViatris Pharma GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1eec46d7-9924-4ac9-9a83-4307634f1772 GET /v1/drugs/1eec46d7-9924-4ac9-9a83-4307634f1772?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "135",
"substance": "CHOLINE FENOFIBRATE",
"productndc": "68180-129",
"dosage_form": "CAPSULE, DELAYED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA200750",
"marketing_category": "ANDA"
}See everything about choline fenofibrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.